Vaccines

Evaluate the potential for products that provide protection against disease

The global demand for vaccines has risen dramatically because of the COVID-19 pandemic and the market is predicted to reach $100bn dollars in the next 5-6 years.

Research Partnership has significant experience in both adult and paediatric vaccine market research, covering HPV, Hepatitis A, Hepatitis E, Sp Pneumonia, Norovirus and Rotavirus, Influenza, Herpes Zoster, CMV, Hemophilus Influenza and Meningitis, amongst others. 

In particular, we have identified a specific need for research in emerging markets, where often the cost of being vaccinated has to be met by the patient. This has implications for the marketer, who has to determine the true size of the market according to both ability and willingness to pay.

We can help you with:

  • Opportunity and demand assessment

  • Understanding the global and local market opportunity

  • Segmenting the market 

  • Product and portfolio development

  • Brand positioning, launch and beyond

Vaccines resources:

ImageGen.ashx-1

Case study

Find out how we supported forecasting for a new vaccine by identifying the optimal pricing strategy.

Learn more

vaccine infographic

Infographic


Download our complimentary infographic outlining our experience and expertise in vaccines.

View

Vaccine infographic-1

Infographic

Download our infographic exploring the vaccine opportunity in Asia.


View

ImageGen.ashx-Oct-30-2020-04-20-40-61-PM

Case study

Find out how we evaluated the private market opportunity for a vaccine for travelers to Sub- Saharan Africa.

Learn more